Using inhibitors of AKT and mTOR, we demonstrated that these kinases play crucial roles in endometrial cancer cell survival and without them, sulforaphane can no longer reduce endometrial cancer cell line viability. This evidence concerns the gene MTOR and endometrial cancer.